Infliximab reduces colectomy in patients with moderate-to-severe ulcerative colitis: colectomy analysis from ACT 1 and ACT 2Sandborn, J.F. Colombel, Anders Olson et al.|Inflammatory Bowel Diseases|2008Cited by 5
P142 Subcutaneously administered golimumab induction therapy improves health states measured by EQ-5D in patients with moderately to severely active ulcerative colitis: results from PURSUIT-SCPeter G. Gibson, W. Sandborn, B. Feagan et al.|Journal of Crohn s and Colitis|2013Cited by 2